A FACTT Aim and Objectives

The aim of this Action is to build a network of European Centres involved in Cell-based Tolerance-inducing Therapies (CTT) that will synergise CTT efforts to maximise gain of knowledge and to fast-forward directed CTT development for treatment of AID, allergy and prevention of graft rejection.

This will create a forum for the exchange and integration of knowledge and expertise and in doing so, will advance the systematic and standardised development and application of CTT in a more efficient and cost-effective way.

The Action aims to achieve this goal by

setting up common protocols between different centres,
defining and validating comparative functional parameters for safe CTT product application and
integrating and standardising immune monitoring of CTT.